Target intelligence / Profile preview

Tubulin polymerization promoting protein 1 (TPPP1)

Target
TPPP1
Molecular classification
Microtubule-associated protein (MAP), Cytoskeletal protein, Other (not a classical receptor, enzyme, or transporter)
01

Overview

Tubulin polymerization promoting protein 1 (TPPP1, also called TPPP or p25) is a microtubule-associated protein highly expressed in the brain, involved in bundling and stabilizing microtubules, increasing their polymerization, and enhancing microtubule acetylation by inhibiting histone deacetylase 6 (HDAC6). It is implicated in cytoskeletal organization, neuronal growth, cell migration, and has emerged as a potential therapeutic target in cancers (such as pancreatic, colorectal, lung, and bladder cancers) and neurological disorders, though no specific drugs targeting TPPP1 are approved. The canonical name is "Tubulin polymerization promoting protein 1 (TPPP1)", not "Tubulin polymerisation promoter," and it is not itself a receptor, enzyme, or classical druggable protein family member, but represents an emerging target class within microtubule biology.

Other names
TPPPp25TPPP1Tubulin polymerisation-promoting protein
02

Mechanism of action

For TPPP1 itself: Modulates microtubule dynamics by promoting polymerization, bundling, and acetylation. For related drugs: Indirect modulation via tubulin stabilization/destabilization (not specific to TPPP1)

03

Biological functions

Microtubule polymerization and stabilizationMicrotubule acetylation regulation (via inhibition of HDAC6)Cytoskeletal organizationNeuronal function: axonal growth, regeneration, migration, trafficking, synapse formation, myelinationCell division and mitosis modulation
04

Disease associations

Cancer (promotes migration and invasion in pancreatic, colorectal, lung, bladder cancers; lower levels in liver cancer)Neurodegenerative diseases (expressed in neurons, implicated in neurological disorders)Other (possibly involved where cytoskeletal dynamics are disrupted)
05

Safety considerations

Not established for TPPP1-directed therapiesMicrotubule-targeting agents (not TPPP1-specific) have known toxicities including neuropathy, myelosuppression
06

Interacting drugs

No approved drugs directly targeting TPPP1 at present

1 more in the full profile.

07

Biomarkers

TPPP1 expression levels in tumor tissue have been investigated as prognostic/diagnostic markers in some cancer types (low in pancreatic cancer, high in other cancers)

Beyond the preview

Go deeper on Tubulin polymerization promoting protein 1 (TPPP1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Tubulin polymerization promoting protein 1 (TPPP1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call